SlideShare a Scribd company logo
5
Most read
10
Most read
15
Most read
VALIDATION OF ANALYTICAL
PROCEDURE (USFDA)
By Achana Chavhan
M.Pharm (QA)
RSCP, Buldana
• Validation of an analytical procedure is the
process by which it is established, by laboratory
studies, that the performance characteristics of
the procedure meet the requirements for the
intended analytical applications
• Typical analytical performance characteristics
that should be considered in the validation of the
types of procedures described in this document
are listed in Table 1.
Typical Analytical Characteristics
Used in Method Validation
Accuracy
Precision
Specificity
Detection Limit
Quantification Limit
Linearity
Range
Robustness
Accuracy
• The accuracy of an analytical procedure is the
closeness of test results obtained by that
procedure to the true value.
• The accuracy of an analytical procedure should
be established across its range.
• Determination:
• In the case of the assay of a drug substance,
accuracy may be determined by application of the
analytical procedure to an analyte of known purity
(e.g., a Reference Standard) or by comparison of the
results of the procedure with those of a second, well-
characterized procedure, the accuracy of which has
been stated or defined.
• The ICH documents recommend that accuracy
should be assessed using a minimum of nine
determinations over a minimum of three
concentration levels, covering the specified range
Precision
• The precision of an analytical procedure is the
degree of agreement among individual test
results when the procedure is applied repeatedly
to multiple samplings of a homogeneous sample.
• The precision of an analytical procedure is
usually expressed as the standard deviation or
relative standard deviation (coefficient of
variation) of a series of measurements.
• Determination:
• The precision of an analytical procedure is
determined by assaying a sufficient number of
aliquots of a homogeneous sample to be able to
calculate statistically valid estimates of standard
deviation or relative standard deviation(coefficient
of variation).
• The ICH documents recommend that repeatability
should be assessed using a minimum of nine
determinations covering the specified range for the
procedure (i.e., three concentrations and three
replicates of each concentration) or using a
minimum of six determinations at 100% of the test
concentration.
Specificity
• The ICH documents define specificity as the
ability to assess unequivocally the analyte in the
presence of components that may be expected to
be present, such as impurities, degradation
products, and matrix components.
• Determination:
• In the case of qualitative analyses (identification
tests), the ability to select between compounds of
closely related structure that are likely to be present
should be demonstrated.
• This should be confirmed by obtaining positive
results (perhaps by comparison to a known reference
material) from samples containing the analyte.
• For validation of specificity for qualitative and
quantitative determinations by spectroscopic
methods, chapters related to topics such as near-
infrared spectrophotometry, Raman spectroscopy,
and X-ray powder diffraction should be consulted.
Detection Limit
• The detection limit is a characteristic of limit
tests. It is the lowest amount of analyte in a
sample that can be detected, but not necessarily
quantitated, under the stated experimental
conditions.
• The detection limit is usually expressed as the
concentration of analyte (e.g., percentage or
parts per billion) in the sample.
• Determination:
• For noninstrumental procedures, the detection limit
is generally determined by the analysis of samples
with known concentrations of analyte and by
establishing the minimum level at which the analyte
can be reliably detected.
• In the case of instrumental analytical procedures that
exhibit background noise, the ICH documents
describe a common approach, which is to compare
measured signals from samples with known low
concentrations of analyte with those of blank
samples. The minimum concentration at which the
analyte can reliably be detected is established
Quantitation Limit
• The quantitation limit is a characteristic of
quantitative assays for low levels of compounds
in sample matrices, such as impurities in bulk
drug substances and degradation products in
finished pharmaceuticals.
• The quantitation limit is expressed as the
concentration of analyte (e.g., percentage or
parts per billion) in the sample.
• Determination:
• For noninstrumental procedures, the quantitation
limit is generally determined by the analysis of
samples with known concentrations of analyte and
by establishing the minimum level at which the
analyte can be determined with acceptable
Accuracy and Precision.
• For instrumental procedures, the same approach
may be used as for noninstrumental procedures. In
the case of procedures submitted for consideration
as official compendial procedures, it is almost never
necessary to determine the actual quantitation
limit.
Linearity & Range
• The linearity of an analytical procedure is its ability to
elicit test results that are directly, or by a well-defined
mathematical transformation, proportional to the
concentration of analyte in samples within a given range.
• The range of an analytical procedure is the interval
between the upper and lower levels of analyte (including
these levels) that have been demonstrated to be
determined with a suitable level of precision, accuracy,
and linearity using the procedure as written. The range is
normally expressed in the same units as test results (e.g.,
percent or parts per million) obtained by the analytical
procedure.
• Determination:
• Linearity should be established across the range
of the analytical procedure. It should be
established initially by visual examination of a
plot of signals as a function of analyte
concentration of content.
• The range of the procedure is validated by
verifying that the analytical procedure provides
acceptable precision, accuracy, and linearity
when applied to samples containing analyte at
the extremes of the range as well as within the
range.
• It is also recommended that the following
minimum specified ranges should be considered:
• Assay of a drug substance (or a finished
product): From 80% to 120% of the test
concentration
• Determination of an impurity: From 50% to
120% of the acceptance criterion
• For content uniformity: A minimum of 70%–
130% of the test concentration,
• For dissolution testing: ±20% over the specified
range
Robustness
• The robustness of an analytical procedure is a
measure of its capacity to remain unaffected by
small but deliberate variations in procedural
parameters
• Robustness may be determined during
development of the analytical procedure.
validation of analytical procedure USFDA Guidline

More Related Content

PPTX
ICH Q8 Guidline
PDF
Analytical Quality by Design Concise Review on Approach to Enhanced Analytica...
PPTX
Qb D – Quality By Design (4th April 2011)
PPTX
Quality by Design in Pharmaceutical Development
PPTX
Pat process analytical technique
PPTX
Recent advances in pharmaceutical industry
PDF
Q2methodvalidation 161105173750
PPTX
Quality by Design and Process Analytical Technology
ICH Q8 Guidline
Analytical Quality by Design Concise Review on Approach to Enhanced Analytica...
Qb D – Quality By Design (4th April 2011)
Quality by Design in Pharmaceutical Development
Pat process analytical technique
Recent advances in pharmaceutical industry
Q2methodvalidation 161105173750
Quality by Design and Process Analytical Technology

What's hot (20)

PDF
Analytical QBD -CPHI 25-27 July R00
PPTX
Process analytical technology
PPT
Analytical method validation
PPTX
Process Analytical Technology (PAT)
PPTX
Quality Management System.pptx
PPTX
Quality By Design presentation qa.pptx
PPTX
Analytical Method Validation
PPTX
QMS stability testing.pptx
PPT
Analytical Method & Technology Transfer Ispe Guide
PPTX
Fitness for use part 1
PPTX
Quality by design in pharmaceutical development
PDF
Process analytical techniques Esha shah
PPTX
Batch Review And Batch Release.pptx
PPT
Dosage form validation
PPTX
Quality-by-design(QbD) in pharmaceutical development
PPTX
Quality by design ( QbD)
PPTX
ICH & WHO GUIDELINES ON validation
PPTX
ICH Q8 Guidelines
PPTX
Quality control checks in Pharmaceutical industries
PDF
Process analytical technology innovative pharmaceutical development
Analytical QBD -CPHI 25-27 July R00
Process analytical technology
Analytical method validation
Process Analytical Technology (PAT)
Quality Management System.pptx
Quality By Design presentation qa.pptx
Analytical Method Validation
QMS stability testing.pptx
Analytical Method & Technology Transfer Ispe Guide
Fitness for use part 1
Quality by design in pharmaceutical development
Process analytical techniques Esha shah
Batch Review And Batch Release.pptx
Dosage form validation
Quality-by-design(QbD) in pharmaceutical development
Quality by design ( QbD)
ICH & WHO GUIDELINES ON validation
ICH Q8 Guidelines
Quality control checks in Pharmaceutical industries
Process analytical technology innovative pharmaceutical development
Ad

Similar to validation of analytical procedure USFDA Guidline (20)

PPTX
ICH-Q2 AMV
PPTX
analytical method validation.pptx
PPT
Analytical Development of methods in biologics
PDF
Analytical method validation
PDF
Analytical method validation by manoj ingale(best ppts)
PPTX
Ich guidelines on validation for analytical method/equipments
PPT
Analytical methods validation as per ich & usp
PDF
Analytical method validation, ICH Q2 guideline
PPTX
International conference on harmonisation validation of analytical procedures
PPT
Analytical method validation
PPTX
Analytical method validation and processess used in industrt
PPTX
Analytical process validation
PPT
analytical method validation
PPTX
Analytical method validation
PPTX
Analytical method validation
PPTX
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
PPT
Analytical validation
PPTX
INSTRUMENTAL ANALYSIS INTRODUCTION
PDF
Analytical Method Validation basics by Dr. A. Amsavel
PPTX
Validation my ppt
ICH-Q2 AMV
analytical method validation.pptx
Analytical Development of methods in biologics
Analytical method validation
Analytical method validation by manoj ingale(best ppts)
Ich guidelines on validation for analytical method/equipments
Analytical methods validation as per ich & usp
Analytical method validation, ICH Q2 guideline
International conference on harmonisation validation of analytical procedures
Analytical method validation
Analytical method validation and processess used in industrt
Analytical process validation
analytical method validation
Analytical method validation
Analytical method validation
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
Analytical validation
INSTRUMENTAL ANALYSIS INTRODUCTION
Analytical Method Validation basics by Dr. A. Amsavel
Validation my ppt
Ad

More from Archana Chavhan (20)

PPTX
CLINICAL PHARMACY for D.pharm PCI syllabus.pptx
PPTX
INTRODUCTION TO HERBAL FORMULATIONS.pptx
PPTX
PLANT FIBRES USED AS SURGICAL DRESSING.pptx
PPTX
DIURETICS.pptx
PPTX
Herbs as health food.pptx
PPTX
TRADITIONAL SYSTEM OF MEDICINE.pptx
PPTX
CLINICAL PHARMACY.pptx
PPTX
DIFFERENT COMMITTEES IN THE HOSPITAL.pptx
PPTX
SUPPLY CHAIN & INVENTORY CONTROL.pptx
PPTX
DRUG DISTRIBUTION.pptx
PPTX
HOSPITAL PHARMACY.pptx
PPTX
INVENTORY MANAGEMENT OF CENTRAL DRUG STORES.pptx
PPTX
VITAMINS ENZYMES.pptx
PPTX
ANTI-RHEUMATIC.pptx
PPTX
RADIOPHARMACEUTICAL.pptx
PPTX
Pharmaceutical Aids.pptx
PPTX
Antimalarials.pptx
PPTX
Anti Tussives.pptx
PPTX
Anti-tumour.pptx
PPTX
oxytocic.pptx
CLINICAL PHARMACY for D.pharm PCI syllabus.pptx
INTRODUCTION TO HERBAL FORMULATIONS.pptx
PLANT FIBRES USED AS SURGICAL DRESSING.pptx
DIURETICS.pptx
Herbs as health food.pptx
TRADITIONAL SYSTEM OF MEDICINE.pptx
CLINICAL PHARMACY.pptx
DIFFERENT COMMITTEES IN THE HOSPITAL.pptx
SUPPLY CHAIN & INVENTORY CONTROL.pptx
DRUG DISTRIBUTION.pptx
HOSPITAL PHARMACY.pptx
INVENTORY MANAGEMENT OF CENTRAL DRUG STORES.pptx
VITAMINS ENZYMES.pptx
ANTI-RHEUMATIC.pptx
RADIOPHARMACEUTICAL.pptx
Pharmaceutical Aids.pptx
Antimalarials.pptx
Anti Tussives.pptx
Anti-tumour.pptx
oxytocic.pptx

Recently uploaded (20)

PDF
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
PPTX
1 General Principles of Radiotherapy.pptx
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PPTX
Patholysiology of MAFLD/MASLD and Role of GLP 1 agonist in obesity and cardio...
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
LUNG ABSCESS - respiratory medicine - ppt
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
PPT
Breast Cancer management for medicsl student.ppt
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Fundamentals of human energy transfer .pptx
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
post stroke aphasia rehabilitation physician
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
1 General Principles of Radiotherapy.pptx
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
Patholysiology of MAFLD/MASLD and Role of GLP 1 agonist in obesity and cardio...
History and examination of abdomen, & pelvis .pptx
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
LUNG ABSCESS - respiratory medicine - ppt
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
Breast Cancer management for medicsl student.ppt
Neuropathic pain.ppt treatment managment
Fundamentals of human energy transfer .pptx
ASRH Presentation for students and teachers 2770633.ppt
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
Respiratory drugs, drugs acting on the respi system
post stroke aphasia rehabilitation physician
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects

validation of analytical procedure USFDA Guidline

  • 1. VALIDATION OF ANALYTICAL PROCEDURE (USFDA) By Achana Chavhan M.Pharm (QA) RSCP, Buldana
  • 2. • Validation of an analytical procedure is the process by which it is established, by laboratory studies, that the performance characteristics of the procedure meet the requirements for the intended analytical applications • Typical analytical performance characteristics that should be considered in the validation of the types of procedures described in this document are listed in Table 1.
  • 3. Typical Analytical Characteristics Used in Method Validation Accuracy Precision Specificity Detection Limit Quantification Limit Linearity Range Robustness
  • 4. Accuracy • The accuracy of an analytical procedure is the closeness of test results obtained by that procedure to the true value. • The accuracy of an analytical procedure should be established across its range.
  • 5. • Determination: • In the case of the assay of a drug substance, accuracy may be determined by application of the analytical procedure to an analyte of known purity (e.g., a Reference Standard) or by comparison of the results of the procedure with those of a second, well- characterized procedure, the accuracy of which has been stated or defined. • The ICH documents recommend that accuracy should be assessed using a minimum of nine determinations over a minimum of three concentration levels, covering the specified range
  • 6. Precision • The precision of an analytical procedure is the degree of agreement among individual test results when the procedure is applied repeatedly to multiple samplings of a homogeneous sample. • The precision of an analytical procedure is usually expressed as the standard deviation or relative standard deviation (coefficient of variation) of a series of measurements.
  • 7. • Determination: • The precision of an analytical procedure is determined by assaying a sufficient number of aliquots of a homogeneous sample to be able to calculate statistically valid estimates of standard deviation or relative standard deviation(coefficient of variation). • The ICH documents recommend that repeatability should be assessed using a minimum of nine determinations covering the specified range for the procedure (i.e., three concentrations and three replicates of each concentration) or using a minimum of six determinations at 100% of the test concentration.
  • 8. Specificity • The ICH documents define specificity as the ability to assess unequivocally the analyte in the presence of components that may be expected to be present, such as impurities, degradation products, and matrix components.
  • 9. • Determination: • In the case of qualitative analyses (identification tests), the ability to select between compounds of closely related structure that are likely to be present should be demonstrated. • This should be confirmed by obtaining positive results (perhaps by comparison to a known reference material) from samples containing the analyte. • For validation of specificity for qualitative and quantitative determinations by spectroscopic methods, chapters related to topics such as near- infrared spectrophotometry, Raman spectroscopy, and X-ray powder diffraction should be consulted.
  • 10. Detection Limit • The detection limit is a characteristic of limit tests. It is the lowest amount of analyte in a sample that can be detected, but not necessarily quantitated, under the stated experimental conditions. • The detection limit is usually expressed as the concentration of analyte (e.g., percentage or parts per billion) in the sample.
  • 11. • Determination: • For noninstrumental procedures, the detection limit is generally determined by the analysis of samples with known concentrations of analyte and by establishing the minimum level at which the analyte can be reliably detected. • In the case of instrumental analytical procedures that exhibit background noise, the ICH documents describe a common approach, which is to compare measured signals from samples with known low concentrations of analyte with those of blank samples. The minimum concentration at which the analyte can reliably be detected is established
  • 12. Quantitation Limit • The quantitation limit is a characteristic of quantitative assays for low levels of compounds in sample matrices, such as impurities in bulk drug substances and degradation products in finished pharmaceuticals. • The quantitation limit is expressed as the concentration of analyte (e.g., percentage or parts per billion) in the sample.
  • 13. • Determination: • For noninstrumental procedures, the quantitation limit is generally determined by the analysis of samples with known concentrations of analyte and by establishing the minimum level at which the analyte can be determined with acceptable Accuracy and Precision. • For instrumental procedures, the same approach may be used as for noninstrumental procedures. In the case of procedures submitted for consideration as official compendial procedures, it is almost never necessary to determine the actual quantitation limit.
  • 14. Linearity & Range • The linearity of an analytical procedure is its ability to elicit test results that are directly, or by a well-defined mathematical transformation, proportional to the concentration of analyte in samples within a given range. • The range of an analytical procedure is the interval between the upper and lower levels of analyte (including these levels) that have been demonstrated to be determined with a suitable level of precision, accuracy, and linearity using the procedure as written. The range is normally expressed in the same units as test results (e.g., percent or parts per million) obtained by the analytical procedure.
  • 15. • Determination: • Linearity should be established across the range of the analytical procedure. It should be established initially by visual examination of a plot of signals as a function of analyte concentration of content. • The range of the procedure is validated by verifying that the analytical procedure provides acceptable precision, accuracy, and linearity when applied to samples containing analyte at the extremes of the range as well as within the range.
  • 16. • It is also recommended that the following minimum specified ranges should be considered: • Assay of a drug substance (or a finished product): From 80% to 120% of the test concentration • Determination of an impurity: From 50% to 120% of the acceptance criterion • For content uniformity: A minimum of 70%– 130% of the test concentration, • For dissolution testing: ±20% over the specified range
  • 17. Robustness • The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small but deliberate variations in procedural parameters • Robustness may be determined during development of the analytical procedure.